OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Use of Clopidogrel and Proton Pump Inhibitors Alone or in Combinations in Persons with Diabetes in Denmark; Potential for CYP2C19 Genotype-Guided Drug Therapy
Niels Westergaard, Lise Tarnow, Charlotte Vermehren
Metabolites (2021) Vol. 11, Iss. 2, pp. 96-96
Open Access | Times Cited: 12
Niels Westergaard, Lise Tarnow, Charlotte Vermehren
Metabolites (2021) Vol. 11, Iss. 2, pp. 96-96
Open Access | Times Cited: 12
Showing 12 citing articles:
Proton Pump Inhibitor Use and the Risk of Cardiovascular Complications and Death in Older Adults with Diabetes: A Population-Based Cohort Study
Andreana Foresta, Luisa Ojeda Fernandez, G Torrigiani, et al.
Drugs & Aging (2024) Vol. 41, Iss. 3, pp. 239-249
Closed Access | Times Cited: 6
Andreana Foresta, Luisa Ojeda Fernandez, G Torrigiani, et al.
Drugs & Aging (2024) Vol. 41, Iss. 3, pp. 239-249
Closed Access | Times Cited: 6
Predictive Biomarkers and Personalized Therapy: Use of Pharmacogenetic Testing in a Scandinavian Perspective
Niels Westergaard, Trine Meldgaard Lund, Charlotte Vermehren
Basic & Clinical Pharmacology & Toxicology (2025) Vol. 136, Iss. 3
Open Access
Niels Westergaard, Trine Meldgaard Lund, Charlotte Vermehren
Basic & Clinical Pharmacology & Toxicology (2025) Vol. 136, Iss. 3
Open Access
Use of drugs with pharmacogenomics (PGx)‐based dosing guidelines in a Danish cohort of persons with chronic kidney disease, both on dialysis and not on dialysis: Perspectives for prescribing optimization
Niels Westergaard, Morten Baltzer Houlind, Lona Louring Christrup, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 134, Iss. 4, pp. 531-542
Open Access | Times Cited: 3
Niels Westergaard, Morten Baltzer Houlind, Lona Louring Christrup, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 134, Iss. 4, pp. 531-542
Open Access | Times Cited: 3
Proton Pump Inhibitor Use and Risks of Cardiovascular Disease and Mortality in Patients With Type 2 Diabetes
Tingting Geng, Jun‐Xiang Chen, Yanfeng Zhou, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 6, pp. e216-e222
Closed Access | Times Cited: 9
Tingting Geng, Jun‐Xiang Chen, Yanfeng Zhou, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 6, pp. e216-e222
Closed Access | Times Cited: 9
Short-term usage of proton pump inhibitors during admission was associated with increased risk of rehospitalization in critically ill patients with myocardial infarction: a cohort study
Jia-De Zhu, Lijuan Yang, Jiannan Zhao, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 11, pp. 1741-1750
Closed Access | Times Cited: 1
Jia-De Zhu, Lijuan Yang, Jiannan Zhao, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 11, pp. 1741-1750
Closed Access | Times Cited: 1
Prevalence and Safety of Prescribing PPIs with Clopidogrel in Palestine
Abdallah Damin Abukhalil, Tala Al Sheikh, Sandra Muallem, et al.
Patient Preference and Adherence (2023) Vol. Volume 17, pp. 749-759
Open Access | Times Cited: 3
Abdallah Damin Abukhalil, Tala Al Sheikh, Sandra Muallem, et al.
Patient Preference and Adherence (2023) Vol. Volume 17, pp. 749-759
Open Access | Times Cited: 3
Clinical Significance and Patterns of Potential Drug–Drug Interactions in Cardiovascular Patients: Focus on Low-Dose Aspirin and Angiotensin-Converting Enzyme Inhibitors
Yana Anfinogenova, В. А. Степанов, A. M. Chernyavsky, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 15, pp. 4289-4289
Open Access
Yana Anfinogenova, В. А. Степанов, A. M. Chernyavsky, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 15, pp. 4289-4289
Open Access
Treatment of Chronic Inflammatory Diseases – The Potential of Pharmacogenetics
Hela Nazari, Vibeke Andersen, Trine Andresen
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Hela Nazari, Vibeke Andersen, Trine Andresen
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Comparison of Multidrug Use in the General Population and among Persons with Diabetes in Denmark for Drugs Having Pharmacogenomics (PGx) Based Dosing Guidelines
Niels Westergaard, Lise Tarnow, Charlotte Vermehren
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 899-899
Open Access | Times Cited: 3
Niels Westergaard, Lise Tarnow, Charlotte Vermehren
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 899-899
Open Access | Times Cited: 3
Predictive biomarkers and personalized pharmacotherapy
Jan Trøst Jørgensen, Niels Westergaard
Expert Review of Molecular Diagnostics (2022) Vol. 22, Iss. 10, pp. 919-922
Closed Access | Times Cited: 2
Jan Trøst Jørgensen, Niels Westergaard
Expert Review of Molecular Diagnostics (2022) Vol. 22, Iss. 10, pp. 919-922
Closed Access | Times Cited: 2
Proton pump inhibitor induced hypomagnesemia and mortality: mediation analyses in the Diabetes Care System cohort
Emma A. Vermeulen, Judith J. M. Rijnhart, Tiny Hoekstra, et al.
Research Square (Research Square) (2023)
Open Access
Emma A. Vermeulen, Judith J. M. Rijnhart, Tiny Hoekstra, et al.
Research Square (Research Square) (2023)
Open Access
